comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 22:48:13 - browse：24

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

WSS

State of the Union pitch: Bigger Medicare drug price negotiations

Lack of health data on LGBTQ+ people has serious consequences

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Medical students need to learn the potent medicine of empathy

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

The public health thinking behind the CDC’s new Covid guidance

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

The high cost of giving birth even with insurance

Florida health officials providing scant details on measles cases

Duchenne breakthrough therapy leaves behind pioneering families

J&J reports mixed data on next

Medicare proposal to cover medical devices draws a mixed reaction

Immune cells and nerve overgrowth may explain recurring UTI pain

Hepatitis C has a cure — but many Americans still lack access to it

Some medical students still think black patients feel less pain

Continuity nursing helped my family in our darkest PICU moments

Lack of health data on LGBTQ+ people has serious consequences

knowledge

Why we need mandatory labeling of GMO products

State of the Union pitch: Bigger Medicare drug price negotiations

Fetal cell organoids grown from amniotic fluid, study finds

Lack of health data on LGBTQ+ people has serious consequences

The Bio Revolution is changing business and society

Fetal cell organoids grown from amniotic fluid, study finds

focus

hotspot

entertainment

leisure time